Feb. 12 at 9:37 PM
$BBIO 99% tutes? Wtf!!
Federated Hermes boosted its stake in BridgeBio by 53% to 424,695 shares (about 0.22% of the company), and institutional investors/hedge funds now own roughly 99.85% of BBIO.
Analysts are broadly bullish—22 Buy vs. 1 Sell—with a consensus rating of "Moderate Buy" and a consensus price target of
$79.05, while several firms have recently raised targets into the mid‑
$80S–
$110S.
Recent results showed Q3 EPS of –
$0.95 (miss) but revenue of
$120.7M (beat and large YoY growth), and insiders have sold about 387,215 shares (~
$26.3M) over the past 90 days despite owning 18.2% of the stock.
